Ignite Creation Date:
2025-12-24 @ 7:00 PM
Ignite Modification Date:
2025-12-25 @ 4:33 PM
Study NCT ID:
NCT03524157
Status:
COMPLETED
Last Update Posted:
2019-07-19
First Post:
2018-04-25
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects
Sponsor:
Laboratorios Sophia S.A de C.V.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-17
Start Date Type:
ACTUAL
Primary Completion Date:
2018-02-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-03-27
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-25
First Submit QC Date:
None
Study First Post Date:
2018-05-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2018-07-23
Results First Submit QC Date:
None
Results First Post Date:
2019-07-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-09
Last Update Post Date:
2019-07-19
Last Update Post Date Type:
ACTUAL